Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trials - Quiz - MDSpire

Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trials

  • By

  • Shuo Zhao

  • Miaoqin Wu

  • Jingxiang Zhong

  • Baihua Chen

  • Zongming Song

  • Zhang Ming

  • Quanhong Han

  • Suqin Yu

  • Hong Wang

  • Songtao Yuan

  • Jin Yao

  • Mingwei Zhao

  • Xiaohong Meng

  • Feng Wang

  • Jing Lou

  • Yanli Liu

  • Haomin Huang

  • Qinghong Zhou

  • Yuyu Xu

  • Hong Dai

  • Xiaorong Li

  • July 1, 2026

  • 0 min

Share

Original Source(s)

Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trials

  • by Shuo Zhao, Miaoqin Wu, Jingxiang Zhong, Baihua Chen, Zongming Song, Zhang Ming, Quanhong Han, Suqin Yu, Hong Wang, Songtao Yuan, Jin Yao, Mingwei Zhao, Xiaohong Meng, Feng Wang, Jing Lou, Yanli Liu, Haomin Huang, Qinghong Zhou, Yuyu Xu, Hong Dai, Xiaorong Li

  • July 1, 2026

Related Content

Standardizing AI for Dry Eye

Expert consensus aims to set professional standards for the use of AI in dry eye diagnosis, monitoring, and personalized treatment

  • June 29, 2026

  • 3 min
The Benefits of Intravitreal Steroids During Vitrectomy

Triamcinolone acetonide enhances vitreous visualization, facilitates surgical maneuvers, and provides postoperative anti-inflammatory effects.

Getting Surgical Documentation Right